Oxybutynin Chloride Tablet
Product Images NDC 43063-931

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 43063-931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

43063931 Label (43063931)

43063931 Label (43063931)
This is a warning label for a medication called Oxybutynin Chloride USP, with a strength of 5 mg per tablet and comes in a pack of 30 tablets. The medication may cause drowsiness and should be taken without consuming alcohol. The lot number is G19E59 with an expiry date of 11/2020. There is a caution against overdosage, and the package insert should be followed for usage and storage information. The tablets are blue, round, and scored, and the manufacturer is PD-Rx Pharmaceuticals Incorporated, located in Oklahoma City. Call a doctor for medical advice on any side effects, and there are FDA contact details provided. Lastly, it indicates the dosage instructions in both English and Spanish to take the tablets several times a day.*
FDA Label Image

Structural Formula (Figure 1 Structure)

Structural Formula (Figure 1 Structure)
FDA Label Image

Table 1 (Figure 2 Table1)

Table 1 (Figure 2 Table1)
This is a comparison between two different forms of Butynin, R-Oybutynin, and S-Ouybutynin. The data shows the values for parameters including G (ng/mL), Toa (1), AUC (ng=h/mL), and UGy (ngehiml). However, without additional context, it is not clear what these parameters represent.*
FDA Label Image

Figure 1 (Figure 3 Figure1)

Figure 1 (Figure 3 Figure1)
FDA Label Image

Table 2 (Figure 4 Table2)

Table 2 (Figure 4 Table2)
FDA Label Image

Figure 2 (Figure 5 Figure2)

Figure 2 (Figure 5 Figure2)
FDA Label Image

Table 3 (Figure 6 Table3)

Table 3 (Figure 6 Table3)
Oxybutynin Chloride is a medication that can cause various adverse events in the body system. It can lead to urinary tract infections, insomnia, nervousness, dizziness, somnolence, headache, blurred vision, dry mouth, constipation, nausea, dyspepsia, urinary hesitation, and urinary retention. The percentage of occurrence is provided for each adverse event.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.